Header cover image
  • Investing Ideas
  • Indian Pharmaceuticals & Biotech Undervalued based on future growth

Indian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Strides Pharma Science

Market Cap: ₹99.7b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

STAR

₹1,082.20

7D

-2.6%

1Y

20.4%